SBRA logo

Sabra Health Care REIT, Inc. Stock Price

NasdaqGS:SBRA Community·US$5.1b Market Cap
  • 1 Narratives written by author
  • 1 Comments on narratives written by author
  • 16 Fair Values set on narratives written by author

SBRA Share Price Performance

US$20.16
1.64 (8.86%)
US$22.77
Fair Value
US$20.16
1.64 (8.86%)
11.5% undervalued intrinsic discount
US$22.77
Fair Value
Price US$20.16
AnalystConsensusTarget US$22.77

SBRA Community Narratives

·
Fair Value US$22.77 11.5% undervalued intrinsic discount

US Senior Living Demand Will Unlock Future Value

0users have liked this narrative
1users have commented on this narrative
8users have followed this narrative
US$22.77
11.5% undervalued intrinsic discount
Revenue
14.55% p.a.
Profit Margin
20.3%
Future PE
33.61x
Price in 2029
US$28.51

Trending Discussion

Updated Narratives

SBRA logo

SBRA: Sector Repricing And Lower Discount Rate Will Support 2026 Upside

Fair Value: US$22.77 11.5% undervalued intrinsic discount
8 users have set this as their fair value
1 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Good value average dividend payer.

2 Risks
3 Rewards

Sabra Health Care REIT, Inc. Key Details

US$815.7m

Revenue

US$295.7m

Cost of Revenue

US$519.9m

Gross Profit

US$363.8m

Other Expenses

US$156.2m

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
n/a
0.62
63.74%
19.15%
95.6%
View Full Analysis

About SBRA

Founded
2010
Employees
58
CEO
Richard Matros
WebsiteView website
www.sabrahealth.com

Sabra Health Care REIT, Inc. operates as a self-administered, self-managed real estate investment trust that, through its subsidiaries, owns and invests in real estate serving the healthcare industry throughout the United States and Canada. Sabra Health Care REIT, Inc. is incorporated on May 10th, 2010 and is based in Tustin, United States.

Recent SBRA News & Updates

Analysis Article Jun 18

Sabra Health Care REIT (SBRA) Stock Could Be 20.7% Undervalued After Recent Pullback

Recent Performance Puts Sabra Health Care REIT Under Closer Investor Scrutiny Sabra Health Care REIT (SBRA) has drawn investor attention after recent share performance. The stock is down about 14% over the past month and roughly 11% over the past 3 months, despite a positive 1 year total return. See our latest analysis for Sabra Health Care REIT. At a share price of $18.05, Sabra Health Care REIT has seen short term share price momentum fade, even though its 1 year total shareholder return of...
Narrative Update Jun 16

SBRA: Sector Repricing And Lower Discount Rate Will Support 2026 Upside

The analyst fair value estimate for Sabra Health Care REIT has moved slightly higher to $22.77 from $22.69, as analysts factor in updated price targets across the sector along with modest adjustments to revenue growth, discount rate assumptions, profit margin expectations, and future P/E multiples. Analyst Commentary Recent Street research has centered on modestly higher price targets for Sabra Health Care REIT, which helps explain the small upward move in the overall fair value estimate.

Recent updates

No updates